The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2018 | Heritability of MPNs
New classifications for myeloproliferative neoplasms (MPNs) incorporate diseases for which a predisposition is inherited. In this video, recorded at the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, Valeria Santini, MD, of the University of Florence, Florence, Italy, speaks about heritable MPNs and the genetic mutations which are associated with them. She discusses the GATA2 and DDX4 mutations specifically, and explains how such understanding is essential so that patients with inherited mutations do not receive stem cell transplants from family members.
